Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
In Vivo Analysis of Early Neuroblastoma Development using Transgenic Quail |
Stowers Institute for Medical Research / Paul Kulesa, PhD |
Innovation Grants |
2015 |
Missouri |
Identifying Mechanisms of Glucocorticoid Resistance in Pediatric Acute Lymphoblastic |
University of Massachusetts Medical School / Michelle Kelliher, PhD |
Innovation Grants |
2015 |
Massachusetts |
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb |
University of Wisconsin - Madison / Paul Sondel, MD, PhD |
Innovation Grants |
2015 |
Wisconsin |
Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response |
Massachusetts General Hospital / Johnathan Whetstine, PhD |
Innovation Grants |
2015 |
Massachusetts |
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas |
University of California, Davis Medical Center / Paul Knoepfler, PhD |
Innovation Grants |
2015 |
California |
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias |
University of California San Francisco / Jeroen Roose, PhD |
Innovation Grants |
2015 |
California |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |
Functional Dissection of Oncogenic Enhancers in T-ALL |
Columbia University / Daniel Herranz, PhD |
Young Investigator Grants |
2015 |
New York |